Showing results (111-120 of 158) with videos related to

Sort By:
Pageof 16
Neuroimage. Clinical|April 19, 2021
Ultra-high field (7T) functional magnetic resonance imaging in amyotrophic lateral sclerosis: a pilot studyRobert L Barry, Suma Babu, Sheeba Arnold Anteraper, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 27, 2021
Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence ScaleSheena Chew, Katherine M Burke, Ella Collins, et al.
Frontiers in Public Health|February 18, 2025
Racial disparities in acute care utilization among individuals with myasthenia gravisCynthia Qi, Pushpa Narayanaswami, Ashley E L Anderson, et al.
Muscle & Nerve|April 22, 2025
Standardization of Myasthenia Gravis Outcome Measures in Clinical Practice: A Report of the MGFA Task ForceKatherine Ruzhansky, Yuebing Li, Gil I Wolfe, et al.
Annals of Neurology|May 10, 2018
Integrated magnetic resonance imaging and [<sup>11</sup> C]-PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosisMohamad J Alshikho, Nicole R Zürcher, Marco L Loggia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET RadioligandsDonatienne Van Weehaeghe, Suma Babu, Joke De Vocht, et al.
Muscle & Nerve|June 2, 2021
Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patientsCarol Milligan, Nazem Atassi, Suma Babu, et al.
Neuroimage. Clinical|November 22, 2017
Imaging of glia activation in people with primary lateral sclerosisSabrina Paganoni, Mohamad J Alshikho, Nicole R Zürcher, et al.
Muscle & Nerve|February 28, 2025
Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral SclerosisAlexandra Lovett, Sowmya Chary, Suma Babu, et al.
Muscle & Nerve|June 27, 2019
Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidenceAmanda M Dios, Suma Babu, Eric J Granucci, et al.
Pageof 16